News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


FDA votes to approve Novocure Device

Posted on: 03/17/2011

FDA votes to approve Novocure Device


The committee voted for approval of the Novocure TTF100A device for the treatment of recurrent glioblastoma multiforme as a monotherapy!

The FDA will review the vote and make a final decision in a few weeks, but most of the time, they go with the committee recomendations!

I would like to thank all of our members who wrote letters -I presented them to the committee and was told that they made a big impact!





Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557